SSScott H. Soderling

Scott H. Soderling

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Scott H. Soderling has a total of 233 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Latent generative search unlocks de novo design of untapped biomolecular interactions at scale

    by Kieran Didi, Danny Reidenbach, Matthew Penner, Supriya Ravichandran, Marshall Case, Mike Nichols, Erik Swanson, Alex Reis, Maggie Prescott, Yue Qian, et al.

    De novo protein design has advanced rapidly, yet designing binders to polar, solvent-exposed epitopes and small, flexible ligands remains challenging. Such hydrated surfaces and flexible molecules, including carbohydrates, provide few of the hydrophobic contacts favoured by current methods and have largely resisted de novo binders. To address this challenge, here we introduce latent generative search for binder design, a novel framework that uses reward-guided search at inference time to steer the Proteína-Complexa generative model. The model codesigns sequence and structure — generating them together in a continuous latent space — and thereby removes the inverse-folding step on which current methods rely. In a screen of more than one million designs by multiplexed phage display, latent generative search produced more validated binders than every other method tested, its codesigned sequences surpassing post hoc redesign. It delivered high-affinity binders across therapeutic receptors, a viral attachment protein and intracellular signalling targets. Our approach also accessed previously untapped biology, generating the first de novo proteins that bind a free carbohydrate, including one that discriminates between blood-group antigens — a polar, flexible target class beyond the reach of current design methods.


  • Open Access

    Miniaturizing and modifying natural proteins with Raygun

    by Kapil Devkota, Daichi Shonai, Joey Mao, Young Su Ko, Wei Wang, Scott Soderling, Rohit Singh

    Proteins have evolved over billions of years through coordinated substitutions, insertions and deletions, yet computational protein design cannot fully replicate nature’s ability to engineer new proteins from existing templates. Protein language models1,2,3 generate informative per-residue representations, but harnessing them for large-scale, function-preserving sequence modifications has remained beyond reach. Here we introduce Raygun, a generative artificial intelligence framework that enables miniaturization, modification and augmentation of proteins, using a probabilistic encoding of protein sequences constructed from language model embeddings. Our key conceptual advance is to encode each protein not as a sequence of variable length in high-dimensional space, but as a probability distribution in fixed dimensions, making proteins of any length directly commensurable. Controlled by just two parameters governing substitutions and length changes, Raygun can shrink proteins by 10–25% (sometimes more than 50%), expand them beyond their natural size, and introduce extensive sequence diversity, all while preserving predicted structural integrity and functional sites. In cell-based validation, Raygun miniaturized fluorescent proteins (2 shorter than 96% of fluorescent proteins in FPbase) and TurboID, a synthetic biotin ligase that has been widely adopted for proteomics. It also expanded epidermal growth factor (EGF), generating variants with higher EGFR-binding affinity than the wild type. These results show that protein function can be faithfully captured in a length-agnostic representation, enabling the kind of coordinated, large-scale sequence modifications that characterize natural protein evolution.


  • Open Access

    In vivo Proximity & Spatial Proteomics with CRISPR Screening Identify STXBP1 as a Protective Modifier of α-synuclein Toxicity in Dopamine Neurons

    by Daichi Shonai, Julie Kent, Arinze Okafor, Yudong Gao, Pooja Parameswaran, Edwin Bustamante, Biswarathan Ramani, Yarui Diao, Martin Kampmann, Erik Soderblom, et al.

    Summary: Parkinson’s disease (PD) is a disease of adults involving the loss of dopaminergic neurons after a long, asymptomatic, prodromal period. α-synuclein, LRRK2, and VPS35 are linked to familial PD, however, how these mutations predispose dopamine neurons to death during the early prodromal phases remains unclear. Here, we used in vivo native proximity proteomics (iBioID) and dopaminergic neuron-specific subcellular proteomics across multiple PD models to uncover early alterations preceding neuronal loss. Our analyses identified convergent disruptions in synaptic protein abundance, indicating that presynaptic trafficking defects are early events in PD pathogenesis. Using a targeted CRISPR-based genetic screen in dopamine neurons, we demonstrated that mimicking this misregulation of STXBP1 amplifies vulnerability to α-synuclein, implicating it as a previously underappreciated toxicity buffering factor. These findings highlight convergent mechanisms that sensitize dopamine neuronal degeneration and that presynaptic vesicle SNARE-complex proteins could serve as key targets for disease-modifying therapies in PD and related neurodegenerative disorders. Highlights: In vivo native-BioID mapping of multiple Parkinson’s disease (PD) protein interactomes revealed a convergent presynaptic network. iBioID analysis on mutant PD proteins (α-synuclein A30P, LRRK2 G2019S, VPS35 D620N) uncovered mutation-specific shifts in local proximity networks, notably in endocytic and vesicle recycling pathways. Spatial proteomics (iBioCoFrac) of dopamine neurons in vivo identified functional modules with reduced levels of key synaptic proteins in PD models. Comparative proteomics using iBioCoFrac revealed synaptic vesicle regulation as a primary site of molecular convergence and early molecular signatures in dopamine neurons across multiple PD mouse models. An in vivo CRISPR screen pinpointed the presynaptic protein Stxbp1/Munc18-1 as an α-synuclein toxicity modifier in dopaminergic neurons.


  • Open Access

    PD-linked LRRK2 G2019S mutation impairs astrocyte morphology and synapse maintenance via ERM hyperphosphorylation

    by Shiyi Wang, Ryan Baumert, Gabrielle Séjourné, Dhanesh Sivadasan Bindu, Kylie Dimond, Kristina Sakers, Leslie Vazquez, Jessica L Moore, Christabel Xin Tan, Tetsuya Takano, et al.

    Astrocytes are highly complex cells that mediate critical roles in synapse formation and maintenance by establishing thousands of direct contacts with synapses through their perisynaptic processes. Here, we found that the most common Parkinsonism gene mutation, LRRK2 G2019S, enhances the phosphorylation of the ERM proteins (Ezrin, Radixin, and Moesin), components of the perisynaptic astrocyte processes in a subset of cortical astrocytes. The ERM hyperphosphorylation was accompanied by decreased astrocyte morphological complexity and reduced excitatory synapse density and function. Dampening ERM phosphorylation levels in LRRK2 G2019S mouse astrocytes restored both their morphology and the excitatory synapse density in the anterior cingulate cortex. To determine how LRRK2 mutation impacts Ezrin interactome, we used an in vivo BioID proteomic approach, and we found that astrocytic Ezrin interacts with Atg7, a master regulator of autophagy. The Ezrin/Atg7 interaction is inhibited by Ezrin phosphorylation, thus diminished in LRRK2 G2019S astrocytes. Importantly, the Atg7 function is required to maintain proper astrocyte morphology. Our data provide a molecular pathway through which the LRRK2 G2019S mutation alters astrocyte morphology and synaptic density in a brain-region-specific manner.

  • Open Access

    Identification of New Ciliary Signaling Pathways in the Brain and Insights into Neurological Disorders

    by Abdelhalim Loukil, Emma Ebright, Karama Hamdi, Elizabeth Menzel, Akiyoshi Uezu, Yudong Gao, Scott H. Soderling, Sarah C. Goetz

    Primary cilia are conserved sensory hubs essential for signaling transduction and embryonic development. Ciliary dysfunction causes a variety of developmental syndromes with neurological features and cognitive impairment whose basis mostly remains unknown. Despite connections to neural function, the primary cilium remains an overlooked organelle in the brain. Most neurons have a primary cilium; however, it is still unclear how this organelle modulates brain architecture and function, given the lack of any systemic dissection of neuronal ciliary signaling. Here, we present the first in vivo glance at the molecular composition of cilia in the mouse brain. We have adapted in vivo proximity-dependent biotin identification (iBioID), targeting the biotin ligase BioID2 to primary cilia in neurons of male and female mice. We identified tissue-specific signaling networks residing in neuronal cilia, including Eph/Ephrin signaling. We also uncovered a novel connection between primary cilia and gamma-aminobutyric acid signaling. Our iBioID ciliary network presents a wealth of new and neural-specific ciliary signaling proteins and yields new insights into neurological disorders. Our findings are a promising first step in defining the fundamentals of ciliary signaling and their roles in shaping neural circuits and behavior. In the future, this work can be extended to pathological conditions of the brain, with the goal of identifying ciliary signaling pathways disrupted in these disorders and the ultimate aim of finding novel therapeutic strategies.


  • Open Access

    Deep Learning-coupled Proximity Proteomics to Deconvolve Kinase Signaling In Vivo

    by Kanchan Jha, Daichi Shonai, Aditya Parekh, Akiyoshi Uezu, Tomoyuki Fujiyama, Hikari Yamamoto, Pooja Parameswaran, Masashi Yanagisawa, Rohit Singh, Scott H. Soderling

    Deconvolving the substrates of hundreds of kinases linked to phosphorylation networks driving cellular behavior is a fundamental, unresolved biological challenge, largely due to the poorly understood interplay of kinase selectivity and substrate proximity. We introduce KolossuS, a deep learning framework leveraging protein language models to decode kinase-substrate specificity. KolossuS achieves superior prediction accuracy and sensitivity across mammalian kinomes, enabling proteome-wide predictions and evolutionary insights. By integrating KolossuS with CRISPR-based proximity proteomics in vivo, we capture kinase-substrate recognition and spatial context, obviating prior limitations. We show this combined framework identifies kinase substrates associated with physiological states such as sleep, revealing both known and novel Sik3 substrates during sleep deprivation. This novel integrated computational-experimental approach promises to transform systematic investigations of kinase signaling in health and disease.


  • Top Cited Papers
    Open Access

    De novo design of peptide binders to conformationally diverse targets with contrastive language modeling

    by Suhaas Bhat, Kalyan Palepu, Lauren Hong, Joey Mao, Tianzheng Ye, Rema Iyer, Lin Zhao, Tianlai Chen, Sophia Vincoff, Rio Watson, et al.

    Designing binders to target undruggable proteins presents a formidable challenge in drug discovery. In this work, we provide an algorithmic framework to design short, target-binding linear peptides, requiring only the amino acid sequence of the target protein. To do this, we propose a process to generate naturalistic peptide candidates through Gaussian perturbation of the peptidic latent space of the ESM-2 protein language model and subsequently screen these novel sequences for target-selective interaction activity via a contrastive language-image pretraining (CLIP)–based contrastive learning architecture. By integrating these generative and discriminative steps, we create a Peptide Prioritization via CLIP (PepPrCLIP) pipeline and validate highly ranked, target-specific peptides experimentally, both as inhibitory peptides and as fusions to E3 ubiquitin ligase domains. PepPrCLIP-derived constructs demonstrate functionally potent binding and degradation of conformationally diverse, disease-driving targets in vitro. In total, PepPrCLIP empowers the modulation of previously inaccessible proteins without reliance on stable and ordered tertiary structures.


  • Open Access

    The Epilepsy–Aphasia Syndrome Gene, Cnksr2, Plays a Critical Role in the Anterior Cingulate Cortex Mediating Vocal Communication

    by Kazi Hossain, Eda Erata, Lucio Schiapparelli, Scott H. Soderling

    Epilepsy–aphasia syndrome (EAS) is a spectrum of childhood disorders that exhibit complex comorbidities that include epilepsy and the emergence of cognitive and language disorders. CNKSR2 is an X-linked gene in which mutations are linked to EAS. We previously demonstrated Cnksr2 knock-out (KO) mice model key phenotypes of EAS analogous to those present in clinical patients with mutations in the gene. Cnksr2 KO mice have increased seizures, impaired learning and memory, increased levels of anxiety, and loss of ultrasonic vocalizations (USVs). The intricate interplay between these diverse phenotypes at the brain regional and cell-type level remains unknown. Here, we leverage conditional deletion of the X-linked Cnksr2 in a neuronal cell-type manner in male mice to demonstrate that anxiety and impaired USVs track with its loss from excitatory neurons. Finally, we further narrow the essential role of Cnksr2 loss in USV deficits to excitatory neurons of the ACC, a region in mice recently implicated in USV production associated with specific emotional states or social contexts, such as mating calls, distress calls, or social bonding signals. Together, our results reveal Cnksr2-based mechanisms that underlie USV impairments that suggest communication impairments can be dissociated from seizures or anxiety. Furthermore, we highlight the cortical circuitry important for initiating USVs.


  • Open Access

    Miniaturizing, Modifying, and Magnifying Nature’s Proteins with Raygun

    by Kapil Devkota, Daichi Shonai, Joey Mao, Young Su Ko, Wei Wang, Scott Soderling, Rohit Singh

    Proteins have evolved over billions of years through extensive and coordinated substitutions, insertions and deletions (indels). Computational protein design cannot yet fully mimic nature’s ability to engineer new proteins from existing templates. Protein language models generate informative per-residue representations, but leveraging them to execute large-scale, function-preserving mutations and indels has remained beyond reach. We introduce Raygun, a generative AI framework that unlocks efficient miniaturization, modification, and augmentation of proteins, using a novel probabilistic encoding of protein sequences constructed from language model embeddings. Emulating evolution, Raygun shrinks proteins by 10-25% (sometimes over 50%) while preserving predicted structural integrity and fidelity, introduces extensive sequence diversity while preserving functional sites, and can expand proteins beyond their natural size. These capabilities unlock new opportunities in gene therapy and biotechnology. In cell-based validation, Raygun successfully miniaturized fluorescent proteins, two of which are smaller than 96% of fluorescent proteins reported in FPbase, as well as TurboID, a synthetic biotin ligase widely adopted for proteomics. It also successfully expanded Epidermal Growth Factor (EGF), a natural binding partner to the EGFR protein, generating EGF variants with higher binding affinity than the wildtype. Raygun’s conceptual innovations in template-based protein design reveal that protein function can be encoded in a length-independent space. This fundamental insight bridges protein representation learning with evolutionary biology and could unlock the development of more efficient molecular tools and biological therapeutics.


  • Open Access

    Proximity analysis of native proteomes reveals phenotypic modifiers in a mouse model of autism and related neurodevelopmental conditions

    by Yudong Gao, Daichi Shonai, Matthew Trn, Jieqing Zhao, Erik J. Soderblom, S. Alexandra Garcia-Moreno, Charles A. Gersbach, William C. Wetsel, Geraldine Dawson, Dmitry Velmeshev, et al.

    One of the main drivers of autism spectrum disorder is risk alleles within hundreds of genes, which may interact within shared but unknown protein complexes. Here we develop a scalable genome-editing-mediated approach to target 14 high-confidence autism risk genes within the mouse brain for proximity-based endogenous proteomics, achieving the identification of high-specificity spatial proteomes. The resulting native proximity proteomes are enriched for human genes dysregulated in the brain of autistic individuals, and reveal proximity interactions between proteins from high-confidence risk genes with those of lower-confidence that may provide new avenues to prioritize genetic risk. Importantly, the datasets are enriched for shared cellular functions and genetic interactions that may underlie the condition. We test this notion by spatial proteomics and CRISPR-based regulation of expression in two autism models, demonstrating functional interactions that modulate mechanisms of their dysregulation. Together, these results reveal native proteome networks in vivo relevant to autism, providing new inroads for understanding and manipulating the cellular drivers underpinning its etiology.